Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Potentiation of warfarin by dong quai.

Page RL 2nd, Lawrence JD.

Pharmacotherapy. 1999 Jul;19(7):870-6.

PMID:
10417036
2.

Tramadol-warfarin interaction.

Sabbe JR, Sims PJ, Sims MH.

Pharmacotherapy. 1998 Jul-Aug;18(4):871-3.

PMID:
9692666
3.

Warfarin and acetaminophen interaction.

Gebauer MG, Nyfort-Hansen K, Henschke PJ, Gallus AS.

Pharmacotherapy. 2003 Jan;23(1):109-12.

PMID:
12523469
4.

Potential interaction between warfarin and boldo-fenugreek.

Lambert JP, Cormier J.

Pharmacotherapy. 2001 Apr;21(4):509-12.

PMID:
11310527
5.

Possible interaction between warfarin and Lycium barbarum L.

Lam AY, Elmer GW, Mohutsky MA.

Ann Pharmacother. 2001 Oct;35(10):1199-201.

PMID:
11675844
6.

Interaction between gemfibrozil and warfarin: case report and review of the literature.

Dixon DL, Williams VG.

Pharmacotherapy. 2009 Jun;29(6):744-8. doi: 10.1592/phco.29.6.744. Review.

PMID:
19476425
7.
8.

Gynaecomastia and the herbal tonic "Dong Quai".

Goh SY, Loh KC.

Singapore Med J. 2001 Mar;42(3):115-6.

PMID:
11405562
9.

Cranberry and warfarin interaction: a case report and review of the literature.

Haber SL, Cauthon KA, Raney EC.

Consult Pharm. 2012 Jan;27(1):58-65. doi: 10.4140/TCP.n.2012.58. Review.

PMID:
22231999
10.
11.

Leflunomide and warfarin interaction: case report and review of the literature.

Chonlahan J, Halloran MA, Hammonds A.

Pharmacotherapy. 2006 Jun;26(6):868-71. Review.

PMID:
16716139
12.

A simple scheme to initiate oral anticoagulant treatment in outpatients with nonrheumatic atrial fibrillation.

Pengo V, Biasiolo A, Pegoraro C.

Am J Cardiol. 2001 Nov 15;88(10):1214-6. No abstract available.

PMID:
11703979
13.

Chinese herbs and warfarin potentiation by 'danshen'.

Yu CM, Chan JC, Sanderson JE.

J Intern Med. 1997 Apr;241(4):337-9.

14.

Potentiation of fluindione or warfarin by dexamethasone in multiple myeloma and AL amyloidosis.

Sellam J, Costedoat-Chalumeau N, Amoura Z, Aymard G, Choquet S, Trad S, Vignes BL, Hulot JS, Berenbaum F, Lechat P, Cacoub P, Ankri A, Mariette X, Leblond V, Piette JC.

Joint Bone Spine. 2007 Oct;74(5):446-52. Epub 2007 Jul 6.

PMID:
17692552
15.

Interaction between warfarin and the herbal product quilinggao.

Wong AL, Chan TY.

Ann Pharmacother. 2003 Jun;37(6):836-8.

PMID:
12773074
16.

Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated.

Gladstone DJ, Bui E, Fang J, Laupacis A, Lindsay MP, Tu JV, Silver FL, Kapral MK.

Stroke. 2009 Jan;40(1):235-40. doi: 10.1161/STROKEAHA.108.516344. Epub 2008 Aug 28.

17.

Effect of stress on international normalized ratio during warfarin therapy.

Hawk TL, Havrda DE.

Ann Pharmacother. 2002 Apr;36(4):617-20.

PMID:
11918508
18.

The first evaluation of a novel vitamin K antagonist, tecarfarin (ATI-5923), in patients with atrial fibrillation.

Ellis DJ, Usman MH, Milner PG, Canafax DM, Ezekowitz MD.

Circulation. 2009 Sep 22;120(12):1029-35, 2 p following 1035. doi: 10.1161/CIRCULATIONAHA.109.856120. Epub 2009 Sep 8.

19.

A taste of Chinese medicine!

Izzat MB, Yim AP, El-Zufari MH.

Ann Thorac Surg. 1998 Sep;66(3):941-2.

PMID:
9768962
20.

Warfarin therapy for an octogenarian who has atrial fibrillation.

Gage BF, Fihn SD, White RH.

Ann Intern Med. 2001 Mar 20;134(6):465-74. Review.

PMID:
11255522
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk